Chairpersons
Gregory Yh Lip (Liverpool, United Kingdom of Great Britain & Northern Ireland)
Elaine Hylek (Boston, United States of America)
Subtitle
Sponsored by Boehringer Ingelheim
Learning objectives
Evaluate key characteristics of and data on non-Vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation. Discuss the latest guidelines and how to apply recommendations for your patients in cardiology settings.
Presentations
Introduction: Atrial fibrillation patients in focus: clinical cases and guidelines.
Speaker: Elaine Hylek (Boston, United States of America)
Advances in anticoagulation: balancing safety and efficacy.
Speaker: Gregory Yh Lip (Liverpool, United Kingdom of Great Britain & Northern Ireland)
Anticoagulation and comorbidities.
Speaker: Christian Ruff (Boston, United States of America)
Dual versus triple therapy after percutaneous coronary intervention.
Speaker: Jan Steffel (Zurich, Switzerland)
When anticoagulation reversal matters.
Speaker: Elaine Hylek (Boston, United States of America)
Atrial fibrillation patients in focus: clinical cases and guidelines: Q&A.
Discussant: Elaine Hylek (Boston, United States of America), Gregory Yh Lip (Liverpool, United Kingdom of Great Britain & Northern Ireland)
0 Comments